Integra Lifesciences Holdings (STU:IL3) Cyclically Adjusted Book per Share: €16.91 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:IL3 Integra Lifesciences Holdings Corp STU:IL3
74 GF Score
Price €16.40
GF Value €20.79
Valuation Modestly Undervalued
! 11 Warning Signs
View Full Analysis

What is Integra Lifesciences Holdings Cyclically Adjusted Book per Share?

Integra Lifesciences Holdings STU:IL3 +2.50% 74 Cyclically Adjusted Book per Share is €16.91 as of Mar. 2026. GuruFocus rates STU:IL3 with a GF Score™ of 74/100 and a GF Value™ of €20.79 (Modestly Undervalued). The stock has 11 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Integra Lifesciences Holdings's adjusted book value per share for the three months ended in Mar. 2026 was €11.587. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €16.91 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Integra Lifesciences Holdings's average Cyclically Adjusted Book Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Integra Lifesciences Holdings was 14.40% per year. The lowest was 5.90% per year. And the median was 9.40% per year.

As of today (2026-07-16), Integra Lifesciences Holdings's current stock price is €16.40. Integra Lifesciences Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €16.91. Integra Lifesciences Holdings's Cyclically Adjusted PB Ratio of today is 0.97.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Integra Lifesciences Holdings was 6.58. The lowest was 0.46. And the median was 4.19.


Integra Lifesciences Holdings  (STU:IL3) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Integra Lifesciences Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=16.40/16.91
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Integra Lifesciences Holdings was 6.58. The lowest was 0.46. And the median was 4.19.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Integra Lifesciences Holdings Cyclically Adjusted Book per Share Related Terms


Integra Lifesciences Holdings Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Integra Lifesciences Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integra Lifesciences Holdings Cyclically Adjusted Book per Share Chart

Integra Lifesciences Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.21 15.24 15.95 17.52 16.50

Integra Lifesciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 16.17 15.55 16.50 16.91

STU:IL3 vs ATEC, AHCO, INSP: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Integra Lifesciences Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integra Lifesciences Holdings Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integra Lifesciences Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Integra Lifesciences Holdings's Cyclically Adjusted PB Ratio falls into.


STU:IL3
74GF Score
Integra Lifesciences Holdings Corp STU:IL3
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integra Lifesciences Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Integra Lifesciences Holdings's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.587/330.2130*330.2130
=11.587

Current CPI (Mar. 2026) = 330.2130.

Integra Lifesciences Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201606 9.476 241.018 12.983
201609 9.823 241.428 13.435
201612 10.653 241.432 14.570
201703 10.594 243.801 14.349
201706 10.281 244.955 13.859
201709 9.774 246.819 13.076
201712 10.373 246.524 13.894
201803 10.273 249.554 13.593
201806 13.533 251.989 17.734
201809 13.742 252.439 17.976
201812 14.200 251.233 18.664
201903 14.471 254.202 18.798
201906 14.711 256.143 18.965
201909 14.653 256.759 18.845
201912 14.849 256.974 19.081
202003 14.318 258.115 18.317
202006 14.215 257.797 18.208
202009 14.083 260.280 17.867
202012 14.765 260.474 18.718
202103 15.202 264.877 18.952
202106 15.457 271.696 18.786
202109 16.375 274.310 19.712
202112 17.604 278.802 20.850
202203 17.642 287.504 20.263
202206 18.815 296.311 20.968
202209 20.854 296.808 23.201
202212 20.362 296.797 22.655
202303 19.102 301.836 20.898
202306 19.096 305.109 20.667
202309 18.704 307.789 20.067
202312 18.627 306.746 20.052
202403 18.668 312.332 19.737
202406 18.371 314.175 19.309
202409 17.774 315.301 18.615
202412 19.125 315.605 20.010
202503 18.142 319.799 18.733
202506 11.557 322.561 11.831
202509 11.358 324.800 11.547
202512 11.441 324.054 11.658
202603 11.587 330.213 11.587

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €16.91 mean?
Integra Lifesciences Holdings (STU:IL3) has a Cyclically Adjusted Book per Share of €16.91 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Integra Lifesciences Holdings and its competitors.
Is Integra Lifesciences Holdings' Cyclically Adjusted Book per Share too high?
Integra Lifesciences Holdings' current Cyclically Adjusted Book per Share is €16.91. Overall, Integra Lifesciences Holdings has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integra Lifesciences Holdings' Cyclically Adjusted Book per Share compare to ATEC and AHCO?
Integra Lifesciences Holdings' Cyclically Adjusted Book per Share of €16.91 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Integra Lifesciences Holdings and its competitors. Integra Lifesciences Holdings's current Cyclically Adjusted Book per Share is €16.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integra Lifesciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Integra Lifesciences Holdings (STU:IL3) is currently considered Modestly Undervalued. The stock's GF Value™ is €20.79, compared to a current price of €16.40 — trading 21.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €16.91. Integra Lifesciences Holdings' overall GF Score™ is 74/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Integra Lifesciences Holdings (STU:IL3), the current Cyclically Adjusted Book per Share is €16.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integra Lifesciences Holdings (STU:IL3) Overvalued in 2026?

Based on GuruFocus' analysis, Integra Lifesciences Holdings stock appears to be undervalued. The current stock price of €16.40 is trading 21.1% below its estimated GF Value™ of €20.79. GuruFocus considers Integra Lifesciences Holdings to be Modestly Undervalued.

Key valuation signals for STU:IL3:

  • Cyclically Adjusted Book per Share: €16.91
  • GF Value™: €20.79 vs. price of €16.40 (21.1% below fair value)
  • GF Score™: 74/100 with 11 warning signs

No single metric tells the full story. See the STU:IL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integra Lifesciences Holdings Business Description

Other Exchanges IART:USA
Address 1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
74GF Score

Get the complete analysis for STU:IL3

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.40
Price
€20.79
GF Value